ORIGINAL RESEARCH
Jun 10
Tijn P.J. Jansen, Peter Damman et al.
This study found an age-dependent increase in minimal microvascular resistance and decrease in microvascular function, represented by a decreased microvascular resistance reserve, in patients with angina and no obstructive coronary artery disease.
ORIGINAL RESEARCH
Jun 10
Lasse Hubertus Tiroke, Jens Erik Nielsen-Kudsk et al.
This long-term cardiac CT follow-up study of 52 patients who underwent left atrial appendage occlusion with the Amplatzer Amulet device found stable left atrial appendage sealing, low rates of device-related thrombosis, and excellent long-term device durability over a median 5.8-year follow-up period.
ORIGINAL ARTICLE
Jun 10
David del Val, Elvin Kedhi et al.
In diabetic patients with non-ischaemic coronary lesions, the presence of OCT-detected vulnerability features, especially in combination, was associated with a higher risk of adverse cardiovascular events.
ORIGINAL RESEARCH
Jun 3
Coen K.M. Boerhout, Martijn Meuwissen et al.
This study found that the hyperaemic stenosis resistance (HSR) index more accurately identified the presence of inducible ischaemia and was an independent predictor of target vessel failure at 5-year follow-up in patients with chronic coronary syndromes.
EDITORIAL
Jun 10
Bernard De Bruyne, Thabo Mahendiran et al.
The article discusses the need to standardize the assessment of Angina with No Obstructive Coronary Artery (ANOCA) and mentions the ongoing Euro-CRAFT study, which aims to provide prognostic data on ANOCA patients through coronary function testing.
free
NEW ISSUE
Jun 3
From perspectives on left atrial appendage occlusions or original research on the effects of ageing or diabetes and vulnerable plaque to chimney/snorkel stenting during TAV-in-TAV – there’s something for everyone in this issue of EuroIntervention...take a look.
ORIGINAL ARTICLE
May 28
Ryutaro Ikegami, Farouc A. Jaffer et al.
This study found similar early stent healing and 1-year clinical outcomes between ultrathin-strut (60 μm) and thin-strut (80 μm) biodegradable-polymer sirolimus-eluting stents, suggesting that stent strut thickness may not be the sole driver of the observed benefits of these stents.
ORIGINAL ARTICLE
May 28
Angela McInerney, Nieves Gonzalo et al.
This content covers a wide range of cardiology interventions, including coronary, valvular, heart failure, and peripheral vascular procedures.
FLASHLIGHT
Jun 3
Christopher L. Brown, Paul S. Teirstein et al.
A 92-year-old female with prior TAVI underwent TAV-in-TAV with chimney stenting to preserve coronary patency. Bench testing revealed that coronary stent cell-crossing height and second TAV placement are crucial for successful chimney stenting.
NEW ISSUE
May 20
With the excitement of EuroPCR now in the past – and it was a wonderful moment to reconnect with colleagues and learn together – we move forward with thoughtful, original research on topics encompassing devices, techniques and, of course, the well- being of our patients.
ORIGINAL RESEARCH
May 20
Davide Cao, Roxana Mehran et al.
In high bleeding risk patients undergoing non-complex PCI with an everolimus-eluting stent, 1-month DAPT was associated with similar ischemic risk and reduced bleeding compared to 3-month DAPT, regardless of clinical presentation.
EDITORIAL
May 28
Sripal Bangalore, Aloke V. Finn
The content discusses the evolution of stent technology, from thick to ultrathin drug-eluting stents, and the challenges in assessing the clinical outcomes of ultrathin-strut DES.
free
EDITORIAL
May 20
Myeong-Ki Hong, Yong-Joon Lee
Dual antiplatelet therapy with aspirin and a P2Y12 inhibitor is required for 12 months in patients with acute coronary syndrome undergoing percutaneous coronary intervention to prevent ischemic events.
free
CONSENSUS
May 16
Francesco Burzotta, Goran Stankovic et al.
The 2023 European Bifurcation Club meeting discussed the use of IVUS and OCT to optimize PCI on coronary bifurcation lesions, but angiography is expected to remain the primary guidance modality. The EBC reviewed tips and tricks to optimize angiography-guided PCI for these lesions.
free
ORIGINAL RESEARCH
May 10
Taku Asano, Hitoshi Matsuo et al.
The FAVOR III Europe Japan trial aims to randomize 2000 patients to either a QFR-guided or FFR-guided strategy to evaluate whether QFR yields non-inferior 12-month clinical outcomes compared to FFR for intermediate coronary stenosis.
Trending articles
Transcatheter treatment for tricuspid valve disease
Contemporary issues of percutaneous coronary intervention in heavily calcified chronic total occlusions: an expert review from the European CTO Club
Impact of alirocumab on plaque regression and haemodynamics of non-culprit arteries in patients with acute myocardial infarction: a prespecified substudy of the PACMAN-AMI trial
Lifetime management of patients with symptomatic severe aortic stenosis: a computed tomography simulation study
Percutaneous coronary intervention for bifurcation coronary lesions using optimised angiographic guidance: the 18th consensus document from the European Bifurcation Club
Catheter-based therapies in acute pulmonary embolism
Recruitment for placebo-controlled trials of interventional procedures: a patient-centred approach
Histological examination of renal nerve distribution, density, and function in humans
His master’s art, Andreas Grüntzig’s approach to performing and teaching coronary angioplasty
Strategies to minimise bleeding secondary to large-bore vascular access complications: an ounce of prevention is worth a pound of cure
State-of-the-Art Review
10.4244/EIJ-D-21-00695 • Nov 19, 2021
Praz F et al
free
Expert review
10.4244/EIJ-D-22-01096 • Jun 5, 2023
Mashayekhi K et al
free
Clinical research
10.4244/EIJ-D-23-00201 • Jul 17, 2023
Bär S et al
Clinical Research
10.4244/EIJ-D-21-01091 • Aug 5, 2022
Medranda G et al
free
Consensus
10.4244/EIJ-D-24-00160 • May 16, 2024
Burzotta F et al
free
EXPERT REVIEW
10.4244/EIJ-D-17-00437 • Feb 20, 2018
Schultz J et al
free
10.4244/EIJ-D-21-00470 • Dec 17, 2021
Al-Lamee R et al
free
Clinical research
10.4244/EIJ-D-23-00264 • Sep 18, 2023
Struthoff H et al
10.4244/EIJV13I1A2 • May 15, 2017
Meier B
free
Editorial
10.4244/EIJ-E-23-00063 • Mar 18, 2024
Pilgrim T and Maznyczka A
free
